Medical Devices: Page 148


  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    Concept Medical nabs breakthrough designation for sirolimus-coated balloon for PAD

    If granted FDA marketing authorization, the device may compete with paclitaxel devices sold by BD, Medtronic, Boston Scientific, Philips and Cook Medical.

    By David Lim • Aug. 13, 2019
  • Two more notified bodies designated in EU, but pace still lags

    The public database NANDO lists German company Dekra Certification as one of the two notified bodies.

    By Dana Elfin • Updated Aug. 14, 2019
  • the FDA Headquarters Explore the Trendline
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • China grants innovative device designation to Novocure's Optune

    Novocure's Chinese partner now gets the opportunity for more contact with regulators and an expedited review in a market estimated at $96.3 billion this year, up from $53.6 billion in 2016. 

    By Aug. 13, 2019
  • Ambu to pay $3.3M to settle False Claims Act allegations

    The Danish medical device maker is accused of manufacturing products in China and Malaysia and knowingly selling them to U.S. government agencies in violation of the 1979 Trade Agreements Act.

    By Aug. 12, 2019
  • NuVasive looks to tech pipeline, overseas expansion in bid for spine market share

    Some analysts think achieving revenue growth in the mid-single digits could be a challenge, given tough dynamics in the spinal surgery market.

    By Aug. 12, 2019
  • AFib device maker AtriCure to spend up to $300M in SentreHeart buyout

    AtriCure announced Tuesday it completed its acquisition of SentreHeart.

    By Maria Rachal • Updated Aug. 14, 2019
  • CMS rejects industry bid to boost payments for device-based opioid alternatives

    The agency said evidence submitted was plagued by potential conflicts of interest, inadequate sample sizes and lack of peer review.

    By David Lim • Aug. 12, 2019
  • UBS surgeon poll points to neuromodulation market slowdown

    Those surveyed predicted Medtronic would gain the most market share going forward, with Boston Scientific in second place and Abbott in third. 

    By Aug. 9, 2019
  • Radiology societies partner with HP on 3D printing registry

    Doctors hope the point-of-care data will help determine the value of turning medical images into patient-specific surgical models.

    By Aug. 9, 2019
  • Image attribution tooltip
    Kendall Davis
    Image attribution tooltip

    MD Anderson taps Hitachi for $159M proton therapy expansion

    The cancer center will more than double the size of its existing site to meet rising demand amid mixed messages about the viability of running proton therapy centers in the U.S.

    By Aug. 9, 2019
  • Image attribution tooltip
    Brian Tucker Industry Dive Image | courtesy of California Office of Attorney General
    Image attribution tooltip
    Q&A

    California's AG on suing J&J for deceptive mesh marketing, defending ACA

    Xavier Becerra also spoke to MedTech Dive about medical product safety.

    By Dana Elfin • Aug. 8, 2019
  • Cardinal Health posts improved Q4, but medical segment still struggling

    CEO Mike Kaufmann said many of the challenges the company's medical segment faced were "a little bit self-inflicted."

    By Dana Elfin • Aug. 8, 2019
  • Siemens acquires Corindus Vascular Robotics for $1.1B

    The now-completed takeover gives Siemens Healthineers an FDA-cleared and CE-marked system for endovascular coronary and peripheral vascular interventions.

    By David Lim • Updated Oct. 29, 2019
  • Image attribution tooltip
    Livongo
    Image attribution tooltip

    Apple, Eli Lilly research whether devices can detect dementia signs

    The two companies, along with health tech startup Evidation, found promising initial results but concluded additional research is needed.

    By Rebecca Pifer • Aug. 8, 2019
  • Wright Medical rocked by distributor disinterest and staff losses

    "We will be bringing more knife fighters to the knife fight and having more motivated knife fighters in the knife fight," CEO Robert Palmisano said of a rivalry over sales reps.

    By Aug. 8, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA grants breakthrough status to Perfuze stroke device

    The startup is attempting to enter a field fought over by Johnson & Johnson, Medtronic and Stryker.

    By Aug. 8, 2019
  • TransEnterix admits its robotics system falls short for docs amid sales slump

    Senhance has failed to consistently live up to high expectations of physicians used to Intuitive Surgical's devices, TransEnterix execs said. Shares plunged more than 25% on Thursday.

    By Aug. 8, 2019
  • FDA to update paclitaxel device labels with mortality signal warning

    The agency and manufacturers such as BD, Medtronic and Boston Scientific are planning research into the devices' long-term safety profile using new randomized trials and registry datasets.

    By David Lim • Updated Aug. 8, 2019
  • Image attribution tooltip
    Nasdaq
    Image attribution tooltip

    Insulin pump makers post double digit gains amid record patient additions

    Shares in Insulet were up more than 18% Tuesday morning after the company posted 43% revenue growth as more people transition from multiple daily injections. Rival Tandem last week reported a 290% rise in pump shipments.

    By Maria Rachal • Aug. 6, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Abbott recommends removal of certain ICDs due to exposed wires

    FDA said 108 of the devices are recalled in the United States, of which 31 are implanted in patients. 

    By Aug. 6, 2019
  • BD: FDA says Lutonix paclitaxel balloon not approvable for below the knee

    BD is working with FDA to determine what additional data is needed to gain the approval, but it is no longer expected this calendar year, executives said on the company's third quarter earnings call.

    By Updated Aug. 7, 2019
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Zimmer hit with $7.7M in damages in hip implant case

    The company has now paid more than $400 million in metal-on-metal hip implant cases but still expects to pay out around $130 million more in relation to lawsuits involving Durom Cup and similar devices sold by its Biomet unit.

    By Aug. 6, 2019
  • CMS eases breakthrough device path to reimbursement in final rule

    As FDA's Breakthrough Devices Program gains in popularity and designated products reach the market, CMS is preparing to offer another benefit: different standards to achieve coverage.

    By Maria Rachal • Aug. 5, 2019
  • VA software workarounds put patient data at risk: OIG

    The watchdog made several recommendations after determining fixes intended to allow medical devices to interface with the Veterans Health Administration's EHR system compromised patients’ personal information.

    By Aug. 5, 2019
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    B. Braun gets breakthrough status for paclitaxel-coated balloon catheter

    The device will be studied for use in treating patients with coronary artery disease who experience in-stent restenosis and could allow patients to avoid an additional stent implant, the company said.

    By Aug. 5, 2019